Search - tctmd.com

Displaying 221 - 240 of 3032

Sort: Relevancy | Date

Presentation TCT 2024

Reflections on Innovation From a Recent FDA Leader

Presenter: William Maisel

October 27, 2024

Presentation TCT 2024

Extending CV Innovation Beyond MedTech

Presenter: Peter Fitzgerald

October 27, 2024

Presentation TCT 2024

Considerations in Particulate Testing

Presenter: Samuel Raben

October 27, 2024

Presentation TCT 2024

Considerations in Simulated Use Testing

Presenter: Kevin Soucy

October 27, 2024

News Daily News

Michelle Tarver Named New FDA Director of Medical Devices

L.A. McKeown

October 25, 2024

News Daily News

Defying Earlier GLP-1 Data, Study in Teens Sees Possible Mental Health Gains

L.A. McKeown

October 22, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

L.A. McKeown

October 15, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Daily News

FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades

Todd Neale

October 02, 2024

News Industry News

Pi-Cardia Receives FDA Market Clearance for ShortCut™

October 01, 2024

News Daily News

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

Todd Neale

September 30, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Conference News ESC 2024

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

L.A. McKeown

August 30, 2024

News Daily News

Cheaper Version of Tirzepatide for Weight Loss Now Available, Lilly Says

Caitlin E. Cox

August 28, 2024

News Daily News

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

Todd Neale

August 23, 2024

News Daily News

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Michael O'Riordan

August 21, 2024

News Daily News

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

L.A. McKeown

August 21, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Daily News

Leadless CRT a Safe, Effective Way to Deliver Pacing: SOLVE-CRT

Caitlin E. Cox

August 05, 2024

Advertisement

Reflections on Innovation From a Recent FDA Leader

Extending CV Innovation Beyond MedTech

Considerations in Particulate Testing

Considerations in Simulated Use Testing

Michelle Tarver Named New FDA Director of Medical Devices

Defying Earlier GLP-1 Data, Study in Teens Sees Possible Mental Health Gains

What’s Going to Be Big at TCT 2024?

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades

Pi-Cardia Receives FDA Market Clearance for ShortCut™

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

Little Pre- and Postmarket Testing for Most Recalled CV Devices

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

Cheaper Version of Tirzepatide for Weight Loss Now Available, Lilly Says

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

Leadless CRT a Safe, Effective Way to Deliver Pacing: SOLVE-CRT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content